Indaptus Therapeutics Inc (INDP) Analysis & Opinions from Experts

Indaptus Therapeutics Inc (NASDAQ: INDP) is -80.59% lower on its value in year-to-date trading and has touched a low of $0.27 and a high of $2.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INDP stock was last observed hovering at around $0.50 in the last trading session, with the day’s gains setting it 5.71%.

Currently trading at $6.21M, the stock is 29.43% and 10.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.39 million and changing 5386676% at the moment leaves the stock -47.39% off its SMA200. INDP registered -46.51% loss for a year compared to 6-month loss of -50.59%. The firm has a 50-day simple moving average (SMA 50) of $0.406 and a 200-day simple moving average (SMA200) of $0.856195.

The stock witnessed a 18.71% gain in the last 1 month and extending the period to 3 months gives it a -31.80%, and is 44.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 36.53% over the week and 16.78% over the month.

Indaptus Therapeutics Inc (INDP) has around 7 employees, a market worth around $7.22M and $0.00M in sales. Distance from 52-week low is 66.75% and -81.40% from its 52-week high. The company has generated returns on investments over the last 12 months (-562.47%).

The EPS is expected to grow by 16.15% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.

Indaptus Therapeutics Inc (INDP) Top Institutional Holders

21.0 institutions hold shares in Indaptus Therapeutics Inc (INDP), with institutional investors hold 20.73% of the company’s shares. The shares outstanding are 16.03M, and float is at 12.90M with Short Float at 7.94%. Institutions hold 13.08% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 0.26 million shares valued at $0.54 million. The investor’s holdings represent 3.0355% of the INDP Shares outstanding. As of 2024-06-30, the second largest holder is INVESTMENT HOUSE LLC with 0.1 million shares valued at $0.22 million to account for 1.2134 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 59309.0 shares representing 0.7025% and valued at over $0.13 million, while STRATEGY ASSET MANAGERS LLC holds 0.537 of the shares totaling 45336.0 with a market value of $86592.0.

Indaptus Therapeutics Inc (INDP) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.